Log In
Print
BCIQ
Print
Print this Print this
 

Megace ES, megestrol acetate

  Manage Alerts
Collapse Summary General Information
Company Par Pharmaceutical Cos. Inc.
DescriptionOral suspension that utilizes NanoCrystal dispersion technology
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationCachexia
Indication DetailsTreat cachexia in AIDS patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today